Technophage has been awarded by IAPMEI (Agency for Competitiveness and Innovation) with the distinction of 'PME líder'. This certification...
U.S. FDA has just cleared the IND application of bacteriophage cocktail TP-102 to initiate Phase I/IIa clinical trial. TP-102 is a cocktail of five...
In 2019, Technophage was among the top 100 companies with the highest R&D investment in Portugal. According to the provisional results of...
Invest in our products
Learn more about GMP manufacturing
Who we are, What we do
TechnoPhage is committed to the development of biological and chemical products for infection, neurosciences and ophthalmology